title: Esthesioneuroblastoma: Results and Outcomes of a Single Institution's Experience.
abstract: OBJECTIVE
  Analysis of outcomes of a cohort of patients with esthesioneuroblastoma.
  
  
  METHODS
  Retrospective cohort analysis.
  
  
  METHODS
  PATIENTS presenting with esthesioneuroblastoma from 1994 to 2006 in a tertiary care academic medical center.
  
  
  METHODS
  Fifteen consecutive patients diagnosed as having esthesioneuroblastoma were treated during this time period using a subcranial resection. The mean follow-up is 75 months (range, 2 to 240 mos).
  
  
  RESULTS
  The overall survival was 100% and the overall disease-free survival was 49% and 24% at 5 and 15 years, respectively. PATIENTS treated with radiation therapy following surgical resection had a 5- and 15-year disease-free survival of 83.3% compared with a 5- and 15-year disease-free survival of 26.7% and 0%, respectively, for patients whose initial treatment was surgery alone. The mean time to recurrence was 82.1 months. None of the patients had a decrease in Karnofsky Performance Score following subcranial resection.
  
  
  CONCLUSIONS
  PATIENTS with esthesioneuroblastoma whose initial treatment consists of surgical resection followed by radiation therapy have a longer disease-free survival than patients treated with surgery alone. However, initial treatment modality did not have an effect on survival. Long-term, close follow-up is necessary to identify recurrences, which can be treated with a high degree of success.
authors.affiliation: Department of Otolaryngology, University of Michigan, Ann Arbor, Michigan.
authors.forename: P Daniel
authors.initials: PD
authors.lastname: Ward
authors.forename: Jason A
authors.initials: JA
authors.lastname: Heth
authors.forename: B Gregory
authors.initials: BG
authors.lastname: Thompson
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Marentette